photo
Speaker

Anthony DeBoer

VP ,BUSINESS DEVELOPMENT, SYNAFFIX BV
Oss, Netherlands
Prior to joining Synaffix in 2014, Anthony served as the Associate Director of Business Development at Allozyne, a Seattle-based biotech, where he was focused on partnering efforts around pipeline programs and antibody-drug conjugate technology leading up to an acquisition by MedImmune. Previously, he studied in the laboratory of Dr. Irv Weissman at the Stanford Institute for Stem Cell Biology and Regenerative Medicine. Anthony is a published co-author in Nature and PNAS and holds a BSc in Biotechnology from Seattle Pacific University.
Speaking In
2:00 PM - 2:15 PM (PDT)
Tuesday, June 14
Synaffix BV is a biotech company that has established a proprietary, clinical-stage technology…